Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$407M |
| 2 |
ExxonMobil
XOM
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$200M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$43M |
| 3 |
BCE
BCE
|
+$39M |
| 4 |
PETM
PETSMART INC
PETM
|
+$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 10.89% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTOR
1501
DELISTED
MERITOR, Inc.
MTOR
| $1.5M | ﹤0.01% |
119,200
+2,200
| +2% | +$30.6K |
|
1502
Axos Financial
AX
$5.72B
| $1.5M | ﹤0.01% |
64,400
+1,600
| +3% | +$35.1K |
|
|
ACOR
1503
DELISTED
Acorda Therapeutics
ACOR
| $1.49M | ﹤0.01% |
374
+6
| +2% | +$27.5K |
|
|
SHLD
1504
DELISTED
Sears Holding Corporation
SHLD
| $1.49M | ﹤0.01% |
36,057
+800
| +2% | +$29.1K |
|
|
BTU
1505
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $1.49M | ﹤0.01% |
20,213
+213
| +1% | +$21.5K |
|
1506
Brady Corp
BRC
$4.43B
| $1.49M | ﹤0.01% |
52,600
| – | – |
|
|
TAL
1507
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $1.49M | ﹤0.01% |
36,500
| – | – |
|
1508
Brink's
BCO
$4.72B
| $1.48M | ﹤0.01% |
53,700
+1,200
| +2% | +$30.8K |
|
1509
Granite Construction
GVA
$5.41B
| $1.48M | ﹤0.01% |
42,100
| – | – |
|
|
OUTR
1510
DELISTED
OUTERWALL INC
OUTR
| $1.48M | ﹤0.01% |
22,350
| – | – |
|
|
HF
1511
DELISTED
HFF Inc.
HF
| $1.48M | ﹤0.01% |
39,300
+700
| +2% | +$25.2K |
|
1512
Tronox
TROX
$958M
| $1.47M | ﹤0.01% |
72,500
+1,100
| +2% | +$23.4K |
|
|
UNT
1513
DELISTED
UNIT Corporation
UNT
| $1.46M | ﹤0.01% |
52,200
| – | – |
|
|
TUMI
1514
DELISTED
TUMI HLDGS INC COM
TUMI
| $1.46M | ﹤0.01% |
59,700
| – | – |
|
1515
St. Joe Company
JOE
$3.89B
| $1.46M | ﹤0.01% |
78,600
| – | – |
|
1516
Northwest Natural Holdings
NWN
$2.14B
| $1.46M | ﹤0.01% |
30,400
| – | – |
|
1517
Apogee Enterprises
APOG
$888M
| $1.46M | ﹤0.01% |
33,700
+500
| +2% | +$21.9K |
|
1518
Nelnet
NNI
$4.55B
| $1.45M | ﹤0.01% |
30,700
| – | – |
|
|
NTUS
1519
DELISTED
Natus Medical Inc
NTUS
| $1.45M | ﹤0.01% |
36,800
+600
| +2% | +$22.1K |
|
|
CKH
1520
DELISTED
Seacor Holdings Inc.
CKH
| $1.45M | ﹤0.01% |
21,507
-1,034
| -5% | -$71.5K |
|
1521
WD-40
WDFC
$3.09B
| $1.44M | ﹤0.01% |
16,300
+400
| +3% | +$33.6K |
|
1522
Ligand Pharmaceuticals
LGND
$5.76B
| $1.44M | ﹤0.01% |
29,976
| – | – |
|
|
ENLC
1523
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.44M | ﹤0.01% |
44,323
| – | – |
|
1524
PTC Therapeutics
PTCT
$6.01B
| $1.44M | ﹤0.01% |
23,600
+500
| +2% | +$30.5K |
|
1525
Heartland Express
HTLD
$979M
| $1.43M | ﹤0.01% |
60,200
+1,200
| +2% | +$30.4K |
|
Similar funds
Swiss National Bank's Q1 2015 Portfolio in Review
As of Q1 2015, Swiss National Bank held 2,582 positions worth $37.5B, up 40% from $26.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $10.3B of net new capital in Q1 2015, opening 14 new positions and adding to 1,633 existing holdings. Its largest new stake was Infosys: 2,143,352 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BCE, an estimated $39M trimmed.
- Swiss National Bank's largest Q1 2015 buy was Infosys: 2,143,352 shares worth $18.8M.
- Swiss National Bank added most to Apple in Q1 2015, an estimated $407M increase.
- Swiss National Bank's biggest Q1 2015 reduction was BCE, cutting an estimated $39M.
- Swiss National Bank fully exited Allergan Inc in Q1 2015, selling an estimated $58.6M.
- Swiss National Bank's ten largest holdings make up 14% of its $37.5B portfolio in Q1 2015.
- Swiss National Bank opened 14 new positions and closed 36 in Q1 2015.
- Swiss National Bank's portfolio value rose 40% quarter-over-quarter to $37.5B.
Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.